3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Smoking Cessation
8
Lung Neoplasms
4
Tobacco Use Disorder
3
Neoplasms
3
Head and Neck Neoplasms
3
Tobacco Use Cessation
2
Squamous Cell Carcinoma of Head and Neck
2
Smoking
2
Carcinoma, Non-Small-Cell Lung
2
Vaping
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Tobacco Smoking
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Pancreatic Neoplasms
1
Pain
1
Oropharyngeal Neoplasms
1
Neoplasms, Second Primary
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Esophageal Neoplasms
1
Interventions
Temozolomide
2
Radiosurgery
2
Leucovorin
2
Irinotecan
2
Fluorouracil
2
sacubitril and valsartan sodium hydrate drug combination
1
icotinib
1
dostarlimab
1
beta Carotene
1
avelumab
1
alpha-Tocopherol
1
Varenicline
1
Tobacco Use Cessation Devices
1
Therapeutics
1
Thalidomide
1
Radiotherapy
1
Probiotics
1
Panitumumab
1
Nicotine Chewing Gum
1
Myofascial Release Therapy
1
Megestrol Acetate
1
Isotretinoin
1
Folfox protocol
1
Drug Therapy
1
Doxycycline
1
Docetaxel
1
Cryosurgery
1
Clonidine
1
Cetuximab
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neoplasms, Second Primary
×
Varenicline
×
Clear all
NCT04634071
2026-02-02
TTOP
University of Kentucky
Phase 2
Completed
126 enrolled